Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Éva, Katona"'
Autor:
Eszter Lilla Tóth, Rita Orbán-Kálmándi, Zsuzsa Bagoly, Linda Lóczi, Tamás Deli, Olga Török, Sarolta Molnár, Sándor Baráth, Parvind Singh, Zsuzsanna Hevessy, Éva Katona, Miklós Fagyas, Attila Ádám Szabó, Szabolcs Molnár, Zoárd Tibor Krasznai
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundSARS-CoV-2 infection during pregnancy increases the risk of severe obstetrical complications. Detailed evaluation of COVID-19-associated coagulopathy in a pregnancy with stillbirth hasn’t been described so far. Besides knowledge gaps in t
Externí odkaz:
https://doaj.org/article/7831d6277b8345fdbd6d79453f8bc21e
Autor:
Judit Kállai, Réka Gindele, Krisztina Pénzes-Daku, Gábor Balogh, Réka Bogáti, Bálint Bécsi, Éva Katona, Zsolt Oláh, Péter Ilonczai, Zoltán Boda, Ágnes Róna-Tas, László Nemes, Imelda Marton, Zsuzsanna Bereczky
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 5, p 2893 (2024)
Antithrombin (AT) is the major plasma inhibitor of thrombin (FIIa) and activated factor X (FXa), and antithrombin deficiency (ATD) is one of the most severe thrombophilic disorders. In this study, we identified nine novel AT mutations and investigate
Externí odkaz:
https://doaj.org/article/d3799ccc75994a64a076a6fd41045381
Autor:
Edina Gabriella Székely, Rita Orbán-Kálmándi, István Szegedi, Éva Katona, Barbara Baráth, Katalin Réka Czuriga-Kovács, Linda Lóczi, Nikolett Vasas, István Fekete, Klára Fekete, Ervin Berényi, László Oláh, László Csiba, Zsuzsa Bagoly
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundIntravenous administration of recombinant tissue plasminogen activator (rt-PA) fails to succeed in a subset of acute ischemic stroke (AIS) patients, while in approximately 6–8% of cases intracerebral hemorrhage (ICH) occurs as side effect
Externí odkaz:
https://doaj.org/article/6feab28fdea04796a0230ff273a156b8
Autor:
Laura Somodi, Emőke Horváth, Helga Bárdos, Barbara Baráth, Dávid Pethő, Éva Katona, József Balla, Nicola J. Mutch, László Muszbek
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 5, p 4802 (2023)
Macrophages express the A subunit of coagulation factor XIII (FXIII-A), a transglutaminase which cross-links proteins through Nε-(γ-L-glutamyl)-L-lysyl iso-peptide bonds. Macrophages are major cellular constituents of the atherosclerotic plaque; th
Externí odkaz:
https://doaj.org/article/711e6a2975f4487a8e8213de5120fdd6
Autor:
Csaba Matta, Tamás Juhász, János Fodor, Tibor Hajdú, Éva Katona, Csilla Szűcs-Somogyi, Roland Takács, Judit Vágó, Tamás Oláh, Ádám Bartók, Zoltan Varga, Gyorgy Panyi, László Csernoch, Róza Zákány
Publikováno v:
Cell Communication and Signaling, Vol 17, Iss 1, Pp 1-19 (2019)
Abstract Background In vitro chondrogenesis depends on the concerted action of numerous signalling pathways, many of which are sensitive to the changes of intracellular Ca2+ concentration. N-methyl-D-aspartate (NMDA) glutamate receptor is a cation ch
Externí odkaz:
https://doaj.org/article/c5b0e24e55b7450aa895fe0783f7e8e3
Autor:
Réka Bogáti, Éva Katona, Amir H. Shemirani, Enikő Balogh, Helga Bárdos, Viktória Jeney, László Muszbek
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 10, p 5845 (2022)
Plasma factor XIII (pFXIII) is a heterotetramer of FXIII-A and FXIII-B subunits. The cellular form (cFXIII), a dimer of FXIII-A, is present in a number of cell types. Activated FXIII (FXIIIa), a transglutaminase, plays an important role in clot stabi
Externí odkaz:
https://doaj.org/article/6d9dc0d3cd7744d7a205f0de512af863
Autor:
Tamás Köbling, Zita Váradi, Éva Katona, Sándor Somodi, Péter Kempler, Dénes Páll, Miklós Zrínyi
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Objective To predict dietary self-efficacy behaviors in high glycosylated hemoglobin A1c (HbA1c) patients using type D personality (TDP) and other psychosocial measures. Methods A cross-sectional, predictive research design was implemented. Participa
Externí odkaz:
https://doaj.org/article/65b8ba0f98d249a19a44ea40759fddce
Autor:
Éva Katona
Publikováno v:
Thrombosis and Haemostasis.
Autor:
Réka Gindele, Krisztina Pénzes-Daku, Gábor Balogh, Judit Kállai, Réka Bogáti, Bálint Bécsi, Ferenc Erdődi, Éva Katona, Zsuzsanna Bereczky
Publikováno v:
Biomolecules, Vol 11, Iss 4, p 544 (2021)
Antithrombin (AT) is a serine protease inhibitor, its activity is highly accelerated by heparin. Mutations at the heparin-binding region lead to functional defect, type II heparin-binding site (IIHBS) AT deficiency. The aim of this study was to inves
Externí odkaz:
https://doaj.org/article/f502af7ffe504ea482bb9d1edd87e030
Autor:
Zsuzsa Bagoly, Barbara Baráth, Rita Orbán-Kálmándi, István Szegedi, Réka Bogáti, Ferenc Sarkady, László Csiba, Éva Katona
Publikováno v:
Biomolecules, Vol 11, Iss 3, p 347 (2021)
Cross-linking of α2-plasmin inhibitor (α2-PI) to fibrin by activated factor XIII (FXIIIa) is essential for the inhibition of fibrinolysis. Little is known about the factors modifying α2-PI incorporation into the fibrin clot and whether the extent
Externí odkaz:
https://doaj.org/article/fc5fec30aa7b4e1eadc9a316d6435185